EASL-ERN School: Diagnostic and treatment challenges in “difficult-to-manage” patients with autoimmune hepatitis and primary biliary cholangitis
Autoimmune Hepatitis (AIH) and Primary Biliary Cholangitis (PBC) including their variants, encompass a wide spectrum of liver diseases with diverse pathophysiology, clinical presentation (or characteristics), management and prognosis. Aims of this course are to (1) recognize red flags for the diagnosis of AIH and PBC, (2) apply diagnostic techniques according to clinical indications, (3) correctly interpret available clinical, laboratory and histological data, (4) provide an overview of the new therapeutic armamentarium, and (5) provide guidance on diagnosis and treatment options in difficult to manage patients. The course directors and the faculty members are well known physicians in the field and have the experience to achieve the abovementioned aims.
School Organisers: Prof. George N. Dalekos, Prof. Pietro Invernizzi and Prof. Dina G. Tiniakos
Learning objectives
- Bring together hepatology experts, young hepatologists and/or young pathologists involved in the study, diagnosis, and treatment of “difficult-to-manage” patients with AIH or PBC in a highly interactive educational setting; facilitate a robust dialogue among attendees through interactive sessions
- Interpret updated and advanced diagnostic tools for recognising patients with AIH and PBC
- Recognise and manage patients with variant forms of AIH and PBC
- Improve patients’ adherence to treatment
- Diagnose, treat and follow-up special patient populations with AIH or PBC such as pregnant, elderly, patients with advanced disease or with comorbidities
- Review the updated definitions of response criteria and endpoints in AIH and PBC
- Discuss management of non-responsive patients to 1st line therapies
- Apply new treatment modalities for AIH and PBC
Target audience
- Hepatologists
- Clinical scientist
- Paediatric hepatologists
- Pathologists
Top 3 reasons to attend
- Understand and recognize pitfalls in diagnosing patients with AIH or PBC
- Diagnose and treat “difficult” patients with variant and specific forms of AIH or PBC
- Translate best clinical practice guidelines for AIH and PBC into daily routine practice